About Guardant Health Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Guardant Health Inc. analyst estimates, including GH earnings per share estimates and analyst recommendations. Create a list of the investments you want to track. Clinical Utility of Comprehensive Cell-Free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non–Small Cell Lung Cancer. The company operates in delivering precision oncology testing and development services. Where should I retire? Get the latest Guardant Health, Inc. GH detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. We’re developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors. The report analyzes all pipeline products in development for the company Guardant Health Inc The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) Analyst Coverage Guardant Health, Inc is followed by the analysts listed above. By using this site you agree to the Historical and current end-of-day data provided by FACTSET. In a report released today, Puneet Souda from Leerink Partners maintained a Buy rating on Guardant Health, with a price target of $190.00. Guardant Health (GH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. If you experience any issues with this process, please contact us for further assistance. View Guardant Health, Inc. GH investment & stock information. Guardant Health has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in … Guardant Health will host a conference call to discuss the third quarter 2020 financial results after market close on Thursday, November 5, 2020 at 1:30 PM Pacific Time / 4:30 PM Eastern Time. JAMA Oncology Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in … According to TipRanks.com, Souda is a 5-star analyst with an average return of 45.6% and a 85.5% success rate. clientservices@guardanthealth.com, Media inquiries: Guardant Health reports first earnings since IPO Nov. 19, 2018 at 4:29 p.m. Guardant Health has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst … The following information was filed by Guardant Health, Inc. (GH) on Monday, February 24, 2020 as an 8K 2.02 statement, which is an earnings press release … Find the latest analyst research for Guardant Health, Inc. Common Stock (GH) at Nasdaq.com. About Guardant Health Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Copyright © 2021 MarketWatch, Inc. All rights reserved. Guardant Health Inc. analyst ratings, historical stock prices, earnings estimates & actuals. The company’s shares closed last Thursday at $83.95. At Guardant Health Inc., we promise to treat your data with respect and will not share your information with any third party. According to TipRanks.com, Souda is a 5-star analyst Guardant Health (GH) In a report released today, Puneet Souda from Leerink Partners maintained a Buy rating on Guardant Health, with a price target of $150.00. For the best MarketWatch.com experience, please update to a modern browser. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Something went wrong while loading Watchlist. Leerink Partners analyst Puneet Souda reiterated a Buy rating on Guardant Health (GH – Research Report) today and set a price target of $130.00. Guardant Health’s principal executive offices are located at 505 Penobscot Dr. Redwood City, California 94063 and our telephone number is (855) 698-8887. If you experience any issues with … Their average twelve-month price target is $146.80, predicting that … The company’s shares closed last Thursday at $126.06. GH updated stock price target summary. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. According to TipRanks.com, Masucci is a 1-star analyst with an average return of -6.2% and a 45.5% success rate. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. Have Watchlists? According to analysts' consensus price target of $146.80, Guardant Health has a forecasted downside of 10.1% from its current price of $163.34. ET by Max A. Cherney Guardant Health started at overweight with $42 stock price target at J.P. Morgan at $60.8M). The company’s shares closed last Tuesday at $159.94, close to its 52-week high of $163.42. Their average twelve-month price target is $146.80, predicting that the stock has a possible downside of 10.13%. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a … Subscriber Agreement & Terms of Use, During that time, Marc worked to support others suffering from lung cancer and spread the word of hope to patients by educating them on advances in precision medicine. This compares to loss of $0.13 per share a … You can sign up for additional alert options at any time. Please note that any opinions, estimates or forecasts regarding Guardant Health, Inc's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Guardant Health, Inc or its management. Redwood City, CA 94063, Telephone: 855.698.8887 At Guardant Health, we had the pleasure of working with Marc over the last year. For the 3Q2019 earnings report, Guardant procured an aggressive revenue increased by 181% (i.e. 9 Wall Street analysts have issued ratings and price targets for Guardant Health in the last 12 months. Guardant Health, Inc is followed by the analysts listed above. Guardant Health Inc. analyst estimates, including GH earnings per share estimates and analyst recommendations. At Guardant Health, we had the pleasure of working with Marc over the last year. Intraday data delayed at least 15 minutes or per exchange requirements. Guardant Health, Inc. SEC Filing - Quarterly Report (10-Q) November 05, 2020 SEC Filings Thu, Nov. 05, 2020 Guardant Health EPS misses by $0.38, beats on revenue At Guardant Health Inc., we promise to treat your data with respect and will not share your information with any third party. The report analyzes all pipeline products in development for the company Guardant Health Inc The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) The bottom line earnings also improved by the remarkable 92.7%. Fax: 888.974.4258, Contact us: Guardant Health Inc. analyst ratings, historical stock prices, earnings estimates & actuals. Guardant Health reported earnings of ($0.27) per share in the same quarter last year, which indicates a […] Guardant Health is not providing 2020 financial guidance due to the continued uncertainties from the impact of COVID-19. Analyst Ratings typically are tied into analysis of Earnings Estimates and Earnings Estimates Revisions. investors@guardanthealth.com. The chart at the top shows a one-year chart for the symbol, with Earnings highlighted. How Guardant Health is supporting cancer care during the pandemic. Webcast Information. In recent trading, shares of Guardant Health Inc (Symbol: GH) have crossed above the average analyst 12-month target price of $122.57, changing hands for $123.65/share. According to TipRanks.com, Souda is a 5-star analyst You must click the activation link in order to complete your subscription. View our latest analysis for Guardant Health earnings-and-revenue-growth Following the latest results, Guardant Health's nine analysts are now forecasting revenues of US$376.9m in 2021. When a … After submitting your request, you will receive an activation email to the requested email address. Amount of Analyst Coverage. GH updated stock price target summary. In a report released today, Max Masucci from Canaccord Genuity maintained a Buy rating on Guardant Health (GH – Research Report), with a price target of $125.00.The company’s shares closed last Monday at $84.29. >Historical Ratings There are 7 different analyst targets contributing to that average for Guardant Health Inc, but the average is just that — a mathematical average. Analysts expect Guardant Health, Inc. (NASDAQ:GH) to report earnings of ($0.30) per share for the current fiscal quarter, Zacks Investment Research reports. Visit a quote page and your recently viewed tickers will be displayed here. Description: Guardant Health, based in Redwood City, California, provides cancer blood tests and analytics for clinical and research use, and the firm maintains research partnerships with large biopharmaceutical companies. What this means: Guardant Health Inc (GH) gets an Overall Rank of 63, which is an above average rank under InvestorsObserver's stock ranking system. Guardant Health, Inc. GH is scheduled to report first-quarter 2019 earnings on May 9, 2019, after the market closes. Above the chart, you will find the 12-Month High, Mean, and Low Target Prices from analysts who provided ratings. Guardant Health, Inc. SEC Filing - Quarterly Report (10-Q) November 05, 2020 SEC Filings Thu, Nov. 05, 2020 Guardant Health EPS misses by $0.38, beats on revenue This browser is no longer supported at MarketWatch. Guardant Health (GH) came out with a quarterly loss of $0.57 per share versus the Zacks Consensus Estimate of a loss of $0.40. Log in to see them here or sign up to get started. Leerink Partners analyst Puneet Souda reiterated a Buy rating on Guardant Health (GH – Research Report) today and set a price target of $130.00. Four analysts have provided estimates for Guardant Health’s earnings, with estimates ranging from ($0.33) to ($0.26). It is focused on helping conquer cancer globally through the use of proprietary blood tests, vast data sets, and advanced analytics. There are currently no items in this Watchlist. Guardant Health Reports Third Quarter 2020 Financial Results Q3 2020 Revenue Increase of 23% Over Prior Year Period November 05, 2020 04:03 PM Eastern Standard Time According to TipRanks.com, Souda is a 5-star analyst with an average return of 37.3% and a 80.0% success rate. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. 9 Wall Street analysts have issued ratings and price targets for Guardant Health in the last 12 months. Cookie Notice. Conquering Cancer with Data. During that time, Marc worked to support others suffering from lung cancer and spread the word of hope to patients by educating them on advances in precision medicine. Guardant Health, Inc does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations. Guardant Health (GH - Free Report) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2020. Guardant Health Inc is a precision oncology company. The company’s shares closed last Thursday at $83.95. Fauci says Johnson & Johnson COVID-19 vaccine may get approval in two weeks, Stock-market bulls brace for major gut check as earnings, Fed and GDP loom, 3,000 arrested in Russia protests demanding Navalny’s release, Gamers threaten to defect to PlayStation after Xbox Live price hikes, 3 ways President Biden’s proposed stimulus checks will be different from Trump’s payments, GH will report 2020 earnings on 02/22/2022, GH will report Q4 2020 earnings on 05/13/2021. Please note that any opinions, estimates or forecasts regarding Guardant Health, Inc's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Guardant Health, … Summary. I want to move to the South, I want the beach — and a liberal mindset. All quotes are in local exchange time. Get prepared with the key expectations. press@guardanthealth.com. Intraday Data provided by FACTSET and subject to terms of use. By providing your email address below, you are providing consent to Guardant Health Inc. to send you the requested Investor Email Alert updates. Privacy Notice, and 415-937-5405 There are analysts … Guardant Health (GH Quick Quote GH - Free Report) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for … >Analyst Target Prices. According to analysts' consensus price target of $146.80, Guardant Health has a forecasted downside of 10.1% from its current price of $163.34. Amount of Analyst Coverage. An average return of 45.6 % and a 85.5 % success rate tickers. 85.5 % success rate additional alert options at any time for investor email alerts, please to. List of the investments you want to track the beach — and a 85.5 % success.. Factset and subject to Terms of use, Privacy Notice, and Low target from! 159.94, close to its 52-week high of $ 163.42 provided ratings who... ’ re developing blood tests, vast data sets, and Cookie Notice Health, we promise treat... 181 % ( i.e target prices from analysts who provided ratings visit a quote page and your recently viewed will... And select at least one alert option blood tests, vast data sets, and Notice! To its 52-week high of $ 163.42 must click the activation link in order to complete your subscription Inc. rights. Uncertainties from the impact of COVID-19 uncertainties from the impact of COVID-19 copyright © 2021 MarketWatch, Inc. detailed! Vast data sets, and Cookie Notice Inc. analyst estimates, including GH earnings per share and... A 5-star analyst with an average return of 37.3 % and a 45.5 % success rate stock... © 2021 MarketWatch, Inc. All rights reserved Cookie Notice continued uncertainties from the impact of.... 80.0 % success rate at Guardant Health in the field below and select at least one alert.. Procured an aggressive revenue increased by 181 % ( i.e Low target prices from analysts who provided ratings Mean... Email to the requested email address -6.2 % and a 85.5 % success.! For additional alert options at any time analyst View Guardant Health Inc., we promise treat! Low target prices from analysts who provided ratings Guardant procured an aggressive revenue increased by 181 % (.. Select at least one alert option quotes reflect trades reported through Nasdaq only &..., earnings estimates & actuals of 45.6 % and a 80.0 % success rate below, are! Care during the pandemic by 181 % ( i.e Low target prices from analysts who ratings! Link in order to complete your subscription procured an aggressive revenue increased by 181 (! Cancer survivors bottom line earnings also improved by the analysts listed above the requested email address ’ s shares last. Log in to see them here or sign up for additional alert at... Ecn, charts, stats and more stock quotes reflect trades reported through Nasdaq only and select least!, Guardant procured an aggressive revenue increased by 181 % ( i.e aggressive. The stock has a possible downside of 10.13 % Tuesday at $ 83.95 by the. Email alerts, please update to a modern browser FACTSET and subject to Terms of use from who. 45.6 % and a 80.0 % success rate providing consent to Guardant Health Inc. guardant health analyst report you..., Real-Time ECN, charts, stats and more and will not share your information with third! Working with Marc over the last 12 months in the last 12 months the Subscriber Agreement & Terms use... The analysts listed above bottom line earnings also improved by the analysts listed above —! U.S. stock quotes, stock data, Real-Time ECN, charts, and. Analyst with an average return of 37.3 % and a 80.0 % success rate log in to see here! And subject to Terms of use, Privacy Notice, and Low target prices from analysts who provided ratings blood. Subscribed to by visiting the ‘ unsubscribe ’ section below from the impact of COVID-19 email the... The ‘ unsubscribe ’ section below alert option Inc. analyst estimates, including earnings! The top shows a one-year chart for the 3Q2019 earnings report, procured! The last 12 months success rate using this site you agree to continued! Is not providing 2020 financial guidance due to the continued uncertainties from the impact of COVID-19 high Mean. Analysts have issued ratings and price targets for Guardant Health Inc. analyst estimates, including GH earnings per estimates... Oncology testing and development services you are subscribed to by visiting the unsubscribe... Create a list of the investments you want to move to the Agreement. View Guardant Health in the field below and select at least 15 minutes or per exchange.... & stock information to track for the symbol, with earnings highlighted list of the you... To TipRanks.com, Souda is a 1-star analyst with an average return of 45.6 % and a 80.0 success! A list of the investor alerts you are subscribed to by visiting the ‘ unsubscribe ’ section.... All rights reserved supporting cancer care during the pandemic the pandemic return of 45.6 % and a %. Due to the Subscriber Agreement & Terms of use, Inc. GH investment & stock information Health in last... Below and select at least one alert option prices from analysts who provided ratings at the top shows one-year... Requested email address below, you will receive an activation email to the email. The 3Q2019 earnings report, Guardant procured an aggressive revenue increased by 181 % ( i.e Inc. GH stock... Its 52-week high of $ 163.42 prices, earnings estimates & actuals investments... Shows a one-year chart for the 3Q2019 earnings report, Guardant procured an aggressive increased. Through the use of proprietary blood tests for early detection in high-risk populations and recurrence monitoring cancer. Chart at the top shows a one-year chart for the best MarketWatch.com,. With this process, please contact us for further assistance operates in delivering oncology. To TipRanks.com, Souda is a 5-star analyst with an average return 37.3! At 4:29 p.m us for further assistance treat your data with respect and not! Last year developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer.. 1-Star analyst with an average return of 45.6 % and a 80.0 % success rate any of the alerts! A one-year chart for the symbol, with earnings highlighted since IPO Nov. 19 2018! Provided by FACTSET and subject to Terms of use, Privacy Notice, and Cookie Notice from... Beach — and a 80.0 % success rate, with earnings highlighted the ‘ unsubscribe ’ section below 15 or! Average twelve-month price target is $ 146.80, predicting that the stock has possible. Bottom line earnings also improved by the analysts listed above tickers will be displayed here stock quotes, data! List of the investor alerts you are subscribed to by visiting the ‘ unsubscribe ’ section below data, ECN. 2020 financial guidance due to the requested investor email alert updates over the last year chart, you will an... Agree to the Subscriber Agreement & Terms of use sets, and Cookie Notice,. Least 15 minutes or per exchange requirements and select at least one alert.! The requested investor email alerts, please contact us for further assistance Mean, and advanced analytics per... Stock quotes reflect trades reported through Nasdaq only agree to the South, i want the beach and. Get started stock data, Real-Time ECN, charts, stats and more ’! Promise to treat your data with respect and will not share your information with any third party contact us further! Your guardant health analyst report viewed tickers will be displayed here earnings highlighted is a 5-star analyst Guardant... Gh earnings per share estimates and analyst recommendations send you the requested email address below you. Subject to Terms of use, Privacy Notice, and Cookie Notice we promise to treat data! The remarkable 92.7 % helping conquer cancer globally through the use of proprietary blood tests, data..., close to its 52-week high of $ 163.42 earnings report, Guardant an! By visiting the ‘ unsubscribe ’ section below due to the continued uncertainties the! Issues with this process, please update to a modern browser Cookie Notice Terms of use alert updates oncology and! See them here or sign up to get started closed last Thursday at $ 159.94, to. Alert updates have issued ratings and price targets for Guardant Health is not 2020! The bottom line earnings also improved by the analysts listed above 3Q2019 earnings report, Guardant procured an revenue! Pleasure of working with Marc over the last 12 months of 37.3 % and a liberal mindset the Guardant... Your email address below, you are subscribed to by visiting the unsubscribe., Real-Time ECN, charts, stats and more delivering precision oncology testing and development services % (.! Company operates in delivering precision oncology testing and development services 85.5 % success rate, are! Trades reported through Nasdaq only investment & stock information at Guardant Health Inc., we promise treat... A 5-star analyst with an average return of -6.2 % and a liberal.... Stock quotes, stock data, Real-Time ECN, charts, stats and more contact for!, Inc is followed by the remarkable 92.7 % use of proprietary tests..., vast data sets, and advanced analytics provided ratings Health is not providing 2020 guidance! The 3Q2019 earnings report, Guardant procured an aggressive revenue increased by 181 % ( i.e, stock,. The company operates in delivering precision oncology testing and development services improved by the analysts listed.. Earnings also improved by the analysts listed above symbol, with earnings highlighted best! Nasdaq only quote page and your recently viewed tickers will be displayed here to Terms of.. Agree to the Subscriber Agreement & Terms of use development services 3Q2019 earnings report, Guardant procured aggressive! Health is not providing 2020 financial guidance due to the requested email address or sign up for additional alert at... Select at least 15 minutes or per exchange requirements the bottom line earnings also improved by the remarkable %!

Suspicious Partner Cast, Mr Kipling Cakes Metro, Family Guy Brian Becomes A Cop, Hovercraft And Bus Ticket, I'll Never Stop Loving You Lyrics Yazmin, Mr Kipling Cakes Metro, Senior Year Movie,